Jbf Capital, Inc. Glycomimetics Inc Transaction History

Jbf Capital, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$2.89 - $4.22 $43,350 - $63,299	-15,000 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$2.69 - $4.24 $111,366 - $175,536	-41,400 Reduced 73.4%	15,000 $56,000
Q4 2020 Feb 11, 2021	BUY	$2.69 - $4.24 $111,366 - $175,536	41,400 Added 276.0%	56,400 $56,000
Q3 2020 Nov 12, 2020	BUY	$3.07 - $5.0 $46,050 - $75,000	15,000 New	15,000 $46,000

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $16.3M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Jbf Capital, Inc. with notifications on news.